Skip to main content
Log in

Atovaquone/proguanil for the treatment and prevention of malaria

  • Clinical Trials Report
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB: Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg 1999, 60:533–541.

    PubMed  CAS  Google Scholar 

  2. Lell B, Luckner D, Ndjave M, et al.: Randomised, placebocontrolled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 1998, 351:709–713.

    Article  PubMed  CAS  Google Scholar 

  3. Shanks GD, Gordon DM, Klotz FW, et al.: Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Clin Infect Dis 1998, 27:494–499.

    PubMed  CAS  Google Scholar 

  4. Sukwa TY, Mulenga M, Chisdaka N, et al.: A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia. Am J Trop Med Hyg 1999, 60:521–525.

    PubMed  CAS  Google Scholar 

  5. van der Berg JD, Duvenage CS, Roskell NS, Scott TR: Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa. Clin ther 1999, 21:741–749.

    Article  PubMed  Google Scholar 

  6. Shapiro TA, Ranasinha CD, Kumar N, Barditch-Crovo P. Prophylactic activity of atovaquone against Plasmodium falciparum in humans. Am J Trop Med Hyg 1999, 60:831–836.

    PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pearson, R.D. Atovaquone/proguanil for the treatment and prevention of malaria. Curr Infect Dis Rep 3, 47–49 (2001). https://doi.org/10.1007/s11908-001-0058-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-001-0058-8

Keywords

Navigation